Article Details
Retrieved on: 2024-10-24 20:52:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monopar secures an exclusive license from AstraZeneca's Alexion for ALXN-1840, aiming to advance treatment for Wilson's disease, a rare genetic ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here